Case Report of A Li-Fraumeni Syndrome-Like Phenotype with A De Novo Mutation in Chek2

Xuehan Zhuang,Yongping Li,Hongzhi Cao,Ting Wang,Jianghao Chen,Jiayun Liu,Liya Lin,Rui Ye,Xinyang Li,Shuang Liu,Weiyang Li,Yonggang Lv,Juliang Zhang,Chenyang He,Xun Xu,Zhen Wang,Chen Huang,Xiao Liu,Ling Wang
DOI: https://doi.org/10.1097/md.0000000000004251
IF: 1.6
2016-01-01
Medicine
Abstract:Background: Cases of multiple tumors are rarely reported in China. In our study, a 57-year-old female patient had concurrent squamous cell carcinoma, mucoepidermoid carcinoma, brain cancer, bone cancer, and thyroid cancer, which has rarely been reported to date.Methods: To determine the relationship among these multiple cancers, available DNA samples from the thyroid, lung, and skin tumors and from normal thyroid tissue were sequenced using whole exome sequencing.Results: The notable discrepancies of somatic mutations among the 3 tumor tissues indicated that they arose independently, rather than metastasizing from 1 tumor. A novel deleterious germline mutation (chr22: 29091846, G->A, p.H371Y) was identified in CHEK2, a Li-Fraumeni syndrome causal gene. Examining the status of this novelmutation in the patient's healthy siblings revealed its de novo origin.Conclusion: Our study reports the first case of Li-Fraumeni syndrome-like in Chinese patients and demonstrates the important contribution of de novo mutations in this type of rare disease.
What problem does this paper attempt to address?